• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, November 5, 2021

Article

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A blog post by PhRMA referenced a study published in the October 2021 issue of The American Journal of Managed Care® (AJMC®). The study, “340B Drug Pricing Program and Hospital Provision of Uncompensated Care,” found that participation in the 340B Drug Pricing Program by general acute care hospitals and critical access hospitals has not been associated with increased provision of uncompensated care.

A piece by Oil City News cited an article published on AJMC.com, the website of AJMC®. The article, “A Timeline of COVID-19 Developments in 2020,” reviewed how the pandemic evolved and progressed through 2020, which closed with the arrival of vaccines but also continued challenges.

Related Videos
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
Lindsey Valenzuela, PharmD, APh, BCACP – screenshot by AJMC
Andrew Wolf, MD, assistant professor of neurology, University of Colorado Anschutz
Lindsey Valenzuela, PharmD, APh, BCACP - screenshot by AJMC
Lindsey Valenzuela, PharmD, APh, BCACP – screenshot by AJMC
Robert Andrews, former US representative for New Jersey and CEO of the Health Transformation Alliance
Robert Andrews, chief executive officer, Health Transformation Alliance
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.